Statistics
Total Visits
Views | |
---|---|
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: the ACROCOMB study | 288 |
Total Visits Per Month
December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: the ACROCOMB study | 8 | 6 | 0 | 1 | 2 | 4 | 9 | 13 | 4 | 7 | 0 |
File Visits
Views | |
---|---|
PuigDmngo_UseLnrtde.pdf | 523 |
Top country views
Views | |
---|---|
United States | 207 |
Sweden | 22 |
Germany | 10 |
China | 7 |
Australia | 5 |
Ukraine | 4 |
Argentina | 3 |
Spain | 3 |
Ireland | 3 |
Japan | 3 |
Top cities views
Views | |
---|---|
Ashburn | 77 |
Fairfield | 44 |
Cambridge | 21 |
Louisville | 11 |
Mountain View | 7 |
Stockholm | 7 |
Dearborn | 6 |
Seattle | 6 |
Jacksonville | 5 |
San Diego | 4 |